This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2019 Apr 11;380(15):1450-1462.

doi: 10.1056/NEJMra1713263.

Hepatocellular Carcinoma

Augusto Villanueva¹

Affiliations

Affiliation

¹ From the Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Graduate School of Biomedical Sciences, and the Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York.

PMID: 30970190
DOI: 10.1056/NEJMra1713263

Review

Hepatocellular Carcinoma

Augusto Villanueva. N Engl J Med. 2019.

. 2019 Apr 11;380(15):1450-1462.

doi: 10.1056/NEJMra1713263.

Author

Augusto Villanueva¹

Affiliation

¹ From the Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Graduate School of Biomedical Sciences, and the Division of Hematology and Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York.

PMID: 30970190
DOI: 10.1056/NEJMra1713263

No abstract available

PubMed Disclaimer

Comment in

Hepatocellular Carcinoma.
Kim YS, Shin SW. Kim YS, et al. N Engl J Med. 2019 Jul 4;381(1):e2. doi: 10.1056/NEJMc1906565. N Engl J Med. 2019. PMID: 31269385 No abstract available.
Hepatocellular Carcinoma.
Duran SR, Jaquiss RDB. Duran SR, et al. N Engl J Med. 2019 Jul 4;381(1):e2. doi: 10.1056/NEJMc1906565. N Engl J Med. 2019. PMID: 31269386 No abstract available.

Similar articles

[Diagnosis and treatment of hepatocellular carcinoma].
Spangenberg HC, Zuber-Jerger I, Mohr L, Thimme R, Blum HE. Spangenberg HC, et al. Dtsch Med Wochenschr. 2004 Feb 20;129(8):368-72. doi: 10.1055/s-2004-819893. Dtsch Med Wochenschr. 2004. PMID: 14961445 Review. German. No abstract available.
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma.
Italian Association for the Study of the Liver (AISF); AISF Expert Panel; AISF Coordinating Committee; Bolondi L, Cillo U, Colombo M, Craxì A, Farinati F, Giannini EG, Golfieri R, Levrero M, Pinna AD, Piscaglia F, Raimondo G, Trevisani F, Bruno R, Caraceni P, Ciancio A, Coco B, Fraquelli M, Rendina M, Squadrito G, Toniutto P. Italian Association for the Study of the Liver (AISF), et al. Dig Liver Dis. 2013 Sep;45(9):712-23. doi: 10.1016/j.dld.2013.01.012. Epub 2013 Feb 23. Dig Liver Dis. 2013. PMID: 23769756
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. Dimitroulis D, et al. World J Gastroenterol. 2017 Aug 7;23(29):5282-5294. doi: 10.3748/wjg.v23.i29.5282. World J Gastroenterol. 2017. PMID: 28839428 Free PMC article. Review.
Managing localized unresectable hepatocellular carcinoma.
Narang-Master J, Rizzolo D. Narang-Master J, et al. JAAPA. 2015 Jan;28(1):27-34. doi: 10.1097/01.JAA.0000458854.46279.d8. JAAPA. 2015. PMID: 25486501 Review.
Octreotide for unresectable hepatocellular carcinoma: beyond the first sight.
Samonakis DN, Christodoulakis N, Kouroumalis EA. Samonakis DN, et al. J Clin Gastroenterol. 2006 Jan;40(1):86-7. doi: 10.1097/01.mcg.0000190778.50279.26. J Clin Gastroenterol. 2006. PMID: 16340641 No abstract available.

See all similar articles

Cited by

Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma.
Ye J, Lin Y, Liao Z, Gao X, Lu C, Lu L, Huang J, Huang X, Huang S, Yu H, Bai T, Chen J, Wang X, Xie M, Luo M, Zhang J, Wu F, Wu G, Ma L, Xiang B, Li L, Li Y, Luo X, Liang R. Ye J, et al. NPJ Precis Oncol. 2024 Nov 15;8(1):262. doi: 10.1038/s41698-024-00752-1. NPJ Precis Oncol. 2024. PMID: 39548284
Value of high frame rate contrast-enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
Fei X, Zhu L, Han P, Jiang B, Li M, Li N, Jiao Z, Clevert DA, Luo Y. Fei X, et al. Insights Imaging. 2024 Nov 15;15(1):273. doi: 10.1186/s13244-024-01821-6. Insights Imaging. 2024. PMID: 39546065
PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.
Okujima Y, Watanabe T, Ito T, Inoue Y, Kasai Y, Imai Y, Nakamura Y, Koizumi M, Yoshida O, Tokumoto Y, Hirooka M, Abe M, Kawakami R, Saitou T, Imamura T, Murakami Y, Hiasa Y. Okujima Y, et al. Sci Rep. 2024 Nov 13;14(1):27768. doi: 10.1038/s41598-024-75142-5. Sci Rep. 2024. PMID: 39532917 Free PMC article.
Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus.
Tong W, Zhong J, Yang Q, Lin H, Chen B, Lu T, Chen J, Luo N. Tong W, et al. Front Immunol. 2024 Oct 28;15:1414121. doi: 10.3389/fimmu.2024.1414121. eCollection 2024. Front Immunol. 2024. PMID: 39530087 Free PMC article.
Reprogramming tumor-associated macrophages and inhibiting tumor neovascularization by targeting MANF-HSF1-HSP70-1 pathway: An effective treatment for hepatocellular carcinoma.
Han D, Ma Q, Ballar P, Zhang C, Dai M, Luo X, Gu J, Wei C, Guo P, Zeng L, Hu M, Jiang C, Liang Y, Wang Y, Hou C, Wang X, Feng L, Shen Y, Shen Y, Hu X, Liu J. Han D, et al. Acta Pharm Sin B. 2024 Oct;14(10):4396-4412. doi: 10.1016/j.apsb.2024.05.001. Epub 2024 May 10. Acta Pharm Sin B. 2024. PMID: 39525584 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information